View Item 

Show simple item record

The Longitudinal Chronic Kidney Disease Study: A Prospective Cohort Study of Predialysis Renal Failure

dc.contributor.authorPerlman, Rachel L.en_US
dc.contributor.authorKiser, Margareten_US
dc.contributor.authorFinkelstein, Fredricen_US
dc.contributor.authorEisele, Georgeen_US
dc.contributor.authorRoys, Eriken_US
dc.contributor.authorLiu, Leien_US
dc.contributor.authorBurrows-Hudson, Sallyen_US
dc.contributor.authorPort, Friedrich K.en_US
dc.contributor.authorMessana, Joseph M.en_US
dc.contributor.authorBailie, Georgeen_US
dc.contributor.authorRajagopalan, Sanjayen_US
dc.contributor.authorSaran, Rajiven_US
dc.date.accessioned2010-06-01T21:00:01Z
dc.date.available2010-06-01T21:00:01Z
dc.date.issued2003-11en_US
dc.identifier.citationPerlman, Rachel L.; Kiser, Margaret; Finkelstein, Fredric; Eisele, George; Roys, Erik; Liu, Lei; Burrows-Hudson, Sally; Port, Friedrich; Messana, Joseph M.; Bailie, George; Rajagopalan, Sanjay; Saran, Rajiv (2003). "The Longitudinal Chronic Kidney Disease Study: A Prospective Cohort Study of Predialysis Renal Failure." Seminars in Dialysis 16(6): 418-423. <http://hdl.handle.net/2027.42/74093>en_US
dc.identifier.issn0894-0959en_US
dc.identifier.issn1525-139Xen_US
dc.identifier.urihttps://hdl.handle.net/2027.42/74093
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=14629599&dopt=citationen_US
dc.description.abstractChronic kidney disease (CKD) is a significant public health problem: every year the number of Americans living with CKD and requiring renal replacement therapy increases. In addition, individuals with CKD have substantially increased morbidity and mortality compared to the general population. The Longitudinal Chronic Kidney Dialysis (LCKD) Study is a multicenter, prospective, observational study of patients with moderate to severe CKD that was designed to better describe the course of the disease and the determinants of patient outcomes. Patients with moderate to severe CKD (glomerular filtration rate [GFR] < 60 ml/min/m 2 ) from four academic nephrology clinics were enrolled between 2000 and 2002. Special cardiac and vascular testing has recently commenced as phase II of this study. Areas that have been or are currently being studied include anemia management, health-related quality of life (HRQOL), medication use, and markers of cardiovascular disease. This article describes the LCKD Study in the context of current knowledge of CKD.en_US
dc.format.extent124206 bytes
dc.format.extent3109 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Science Incen_US
dc.rights2003 Blackwell Publishingen_US
dc.titleThe Longitudinal Chronic Kidney Disease Study: A Prospective Cohort Study of Predialysis Renal Failureen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelInternal Medicine and Specialtiesen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationum* Division of Nephrology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michiganen_US
dc.contributor.affiliationum¶ Department of Biostatistics, Kidney Epidemiology and Cost Center, School of Public Health, University of Michigan, Ann Arbor, Michiganen_US
dc.contributor.affiliationum** University Renal Research and Education Association, Ann Arbor, Michiganen_US
dc.contributor.affiliationum†† Department of Cardiovascular Medicine, University of Michigan, Ann Arbor, Michiganen_US
dc.contributor.affiliationother† Division of Nephrology, Department of Internal Medicine, University of North Carolina–Chapel Hill, Chapel Hill, North Carolinaen_US
dc.contributor.affiliationother† Yale Medical Group, Yale University, New Haven, Connecticuten_US
dc.contributor.affiliationother§ Division of Nephrology, Department of Internal Medicine, Albany Medical College, Albany, New Yorken_US
dc.contributor.affiliationother# Amgen, Inc., Thousand Oaks, Californiaen_US
dc.identifier.pmid14629599en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/74093/1/j.1525-139X.2003.16093.x.pdf
dc.identifier.doi10.1046/j.1525-139X.2003.16093.xen_US
dc.identifier.sourceSeminars in Dialysisen_US
dc.identifier.citedreference1.  U.S. Renal Data System: USRDS 2002 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2002en_US
dc.identifier.citedreferenceCoresh J, Astor BC, Greene T, Eknoyan G, Levey AS: Prevalence of chronic kidney disease and decreased renal function in the adult US population: Third Health and Nutrition Examination Survey. Am J Kidney Dis 41: 1 – 12, 2003en_US
dc.identifier.citedreference3.  The ACE Inhibitors in Diabetic Nephropathy Trial Group: Should all patients with type I diabetes mellitus and microalbuminuria receive angiotensin-converting enzyme inhibitors? Ann Intern Med 134: 370 – 379, 2001en_US
dc.identifier.citedreferenceKshirsagar AV, Joy MS, Hogan SL, Falk RJ, Colindres RE: Effect of ACE inhibitors in diabetic and nondiabetic chronic renal disease: a systematic review of randomized placebo-controlled trials. Am J Kidney Dis 35: 695 – 707, 2000en_US
dc.identifier.citedreferenceJafar TH, Schmid CH, Landa M, Giatras I, Toto R, Remuzzi G, Maschio G, Brenner BM, Kamper A, Zucchelli P, Becker G, Himmelmann A, Bannister K, Landais P, Shahinfar S, de Jong PE, de Zeeuw D, Lau J, Levey AS: Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. Ann Intern Med 135: 73 – 87, 2001en_US
dc.identifier.citedreferencePereira BJ: Optimization of pre-ESRD care: the key to improved dialysis outcomes. Kidney Int 57: 351 – 365, 2000en_US
dc.identifier.citedreferenceStack AG: Impact of timing of nephrology referral and pre-ESRD care on mortality risk among new ESRD patients in the United States. Am J Kidney Dis 41: 310 – 318, 2003en_US
dc.identifier.citedreferenceKinchen KS, Sadler J, Fink N: The timing of specialist evaluation in chronic kidney disease and mortality. Ann Intern Med 137: 479 – 486, 2002en_US
dc.identifier.citedreferenceAvorn J, Bohn RL, Levy E, Levin R, Owen WF, Winkelmayer WC, Glynn RJ: Nephrologist care and mortality in patients with chronic renal insufficiency. Arch Intern Med 162: 2002 – 2006, 2002en_US
dc.identifier.citedreference10.  National Kidney Foundation: Executive summary. In: K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease. New York: National Kidney Foundation, 2002en_US
dc.identifier.citedreference11.  European best practice guidelines in nephrology. Nephrol Dial Transplant 14 ( suppl 5 ): 1 – 50, 1999en_US
dc.identifier.citedreferenceRao M, Kausz AT, Mitchell D, Ratican SH, Lin F, Burrows-Hudson S, Port F, Pereira BJ: The study of treatment for renal insufficiency: data and evaluation (STRIDE), a national registry of chronic kidney disease. Semin Dial 15: 366 – 369, 2002en_US
dc.identifier.citedreferenceWright TJ, Kusek JW, Toto RD, Lee JY, Agodoa LY, Kirk KA, Randall OS, Glassock R: Design and baseline characteristics of participants in the African American Study of Kidney Disease and Hypertension (AASK) pilot study. Control Clin Trials 17 ( 4 suppl ): S3 – S16, 1996en_US
dc.identifier.citedreferenceJager KJ, Merkus MP, Boeschoten EW, Dekker FW, Stevens P, Krediet RT, NECOSAD Study Group: Dialysis in the Netherlands: the clinical condition of new patients put into a European perspective. Nephrol Dial Transplant 14: 2438 – 2444, 1999en_US
dc.identifier.citedreferenceXue JL, St. Peter WL, Ebben JP, Everson SE, Collins AJ: Anemia treatment in the pre-ESRD period and associated mortality in elderly patients. Am J Kidney Dis 40: 1153 – 1161, 2002en_US
dc.identifier.citedreferenceFink JC, Blahut SA, Reddy M, Light PD: Use of erythropoietin before the initiation of dialysis and its impact on mortality. Am J Kidney Dis 37: 348 – 355, 2001en_US
dc.identifier.citedreferenceKorevaar JC, Merkus MP, Jansen MA, Dekker FW, Boeschoten EW, Krediet RT, NECOSAD Study Group: Validation of the KDQOL-SF TM: a dialysis-targeted health measure. Qual Life Res 11: 437 – 447, 2002en_US
dc.identifier.citedreferenceKusek JW, Greene P, Wang SR, Beck G, West D, Jamerson K, Agodoa LY, Faulkner M: Level B for the African American Study of Kidney Disease and Hypertension Trial Study Group. Cross-sectional study of health related quality of life in African Americans with chronic renal insufficiency: the African American Study of Kidney Disease and Hypertension trial. Am J Kidney Dis 39: 513 – 524, 2002en_US
dc.identifier.citedreferenceWare J, Snow KK, Kosinski M, Gandek B: SF-36 health survey: manual & interpretation guide. Boston: Health Institute, 1993en_US
dc.identifier.citedreferenceWare J, Kosinski M, Keller SD: SF-36 physical and mental health summary scales: a user's manual. Boston: Health Institute, 1994en_US
dc.identifier.citedreferenceLopes AA, Bragg-Gresham JL, Satayathum S, McCullough K, Pifer T, Goodkin DA, Mapes DL, Young EW, Wolfe RA, Held PJ, Port FK, Worldwide DOPPS Committee: Health-related quality of life and associated outcomes among hemodialysis patients of different ethnicities in the United States: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 41: 605 – 615, 2003en_US
dc.identifier.citedreferenceWalters BA, Hays RD, Spritzer KL, Fridman M, Carter WB: Health-related quality of life, depressive symptoms, anemia and malnutrition at hemodialysis initiation. Am J Kidney Dis 40: 1185 – 1194, 2002en_US
dc.identifier.citedreferenceKorevaar JC, Jansen MA, Merkus MP, Dekker FW, Boeschoten EW, Krediet RT: Quality of life in predialysis end-stage renal disease patients at the initiation of dialysis therapy. The NECOSAD Study Group. Perit Dial Int 20: 69 – 75, 2000en_US
dc.identifier.citedreferenceLevey AS, Beto JA, Coronado BE, Eknoyan G, Foley RN, Kasiske BL, Klag MJ, Mailloux LU, Manske CL, Meyer KB, Parfrey PS, Pfeffer MA, Wenger NK, Wilson PW, Wright JT: Controlling the epidemic of cardiovascular disease in chronic renal disease: What do we know? What do we need to learn? Where do we go from here? Am J Kidney Dis 32: 853 – 906, 1998en_US
dc.identifier.citedreferenceFoley RN, Parfrey PS, Sarnak MJ: Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 32 ( 5 suppl 3 ): S112 – S119, 1998en_US
dc.identifier.citedreferenceLevey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130: 461 – 470, 1999en_US
dc.identifier.citedreferencePatel UD, Wright G, Roys EC, Finkelstein F, Kiser M, Eisele G, Burrows-Hudson S, Port FK, Saran R: Anemia management among patients with chronic kidney disease. J Am Soc Nephrol 13: 761A, 2002en_US
dc.identifier.citedreferenceBailie G, Roys EC, Eisele G, Kiser M, Finkelstein F, Wolfe RA, Mason N, Port FK, Burrows-Hudson S, Saran R: Medication use in chronic kidney disease (CKD) patients: analysis of the multicenter longitudinal CKD study. Presented at the National Kidney Foundation Clinical Meetings, Am J Kidney Dis 41: A7, 2003en_US
dc.identifier.citedreferenceSaran R, Wolfe RA, Roys EC, Wright G, Kiser M, Eisele G, Finkelstein F, Burrows-Hudson S, Port FK: Predictors of quality of life (Qol) in chronic kidney disease (CKD): cross-sectional analysis in the multicenter longitudinal CKD study. J Am Soc Nephrol 13: 520A, 2002en_US
dc.identifier.citedreferencePerlman R, Roys EC, Finkelstein F, Kiser M, Eisele G, Burrows-Hudson S, Messana J, Port FK, Wolfe RA, Saran R: Quality of life (QOL) in patients with chronic kidney disease (CKD): a longitudinal study. Presented at the National Kidney Foundation Clinical Meetings, Am J Kidney Dis 41: A8, 2003en_US
dc.identifier.citedreferenceFeldman HI, Appel LJ, Chertow GM, Cifelli D, Cizman B, Daugirdas J, Fink JC, Franklin-Becker ED, Go AS, Hamm LL, He J, Hostetter T, Hsu CY, Jamerson K, Joffe M, Kusek JW, Landis JR, Lash JP, Miller ER, Mohler ER 3rd, Muntner P, Ojo AO, Rahman M, Townsend RR, Wright JT; Chronic Renal Insufficiency Cohort (CRIC) Study Investigators. The Chronic Renal Insufficiency Cohort (CRIC) Study: Design and Methods. J Am Soc Nephrol 14(7 Suppl 2): S148 – 153, 2003en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1525-139X.2003.16093.x.pdf
Size:
121.2KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.